Format

Send to

Choose Destination
J Infus Chemother. 1996 Spring;6(2):69-73.

Anthracycline dose intensity: clinical pharmacology and pharmacokinetics of high-dose doxorubicin administered as a 96-hour continuous intravenous infusion.

Author information

1
Department of Medical Oncology and Therapeutics Research, City of Hope Cancer Research Center, Duarte, CA 91010, USA.

Abstract

In this review, the clinical pharmacology of high-dose doxorubicin is examined, and the pharmacokinetics of infusional doxorubicin at standard and high dose are compared. The data developed here, including recent clinical trials of high-dose infusional doxorubicin, demonstrate the safety and efficacy of doxorubicin administration at doses > or = 150 mg/m2 for patients with breast cancer and strongly suggest that the utility of this drug can be substantially increased with appropriate hematopoietic support.

PMID:
8809652
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center